Cargando…

Perioperative versus total neoadjuvant chemotherapy in gastric cancer

BACKGROUND: Perioperative chemotherapy is standard of care management for locally advanced gastric cancer (GC), but a substantial proportion of patients do not complete adjuvant therapy due to postoperative complications and prolonged recovery. Administration of all chemotherapy prior to surgery in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jessica, Greally, Megan, Strong, Vivian E., Coit, Daniel G., Chou, Joanne F., Capanu, Marinela, Maron, Steven B., Kelsen, David P., Ilson, David H., Janjigian, Yelena Y., Ku, Geoffrey Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331735/ https://www.ncbi.nlm.nih.gov/pubmed/37435205 http://dx.doi.org/10.21037/jgo-23-4

Ejemplares similares

Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma
por: Tsai, Charlton, et al.
Publicado: (2022)

Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer
por: Janjigian, Yelena Y., et al.
Publicado: (2015)

Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer
por: Ku, Geoffrey Y., et al.
Publicado: (2021)

Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma
por: Chhabra, Arpit, et al.
Publicado: (2015)

Clinical Importance of Clonal Hematopoiesis in Metastatic Gastrointestinal Tract Cancers
por: Diplas, Bill H., et al.
Publicado: (2023)

Targeting EGFR in Esophagogastric Cancer
por: Maron, Steven B., et al.
Publicado: (2020)

Diffusion-weighted MRI and histogram analysis: assessment of response to neoadjuvant chemotherapy in nephroblastoma
por: Hötker, Andreas M., et al.
Publicado: (2021)

Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer
por: Maron, Steven B., et al.
Publicado: (2023)

Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior
por: Sahin, Ibrahim H., et al.
Publicado: (2018)

Integrative analysis of functional genomic annotations and sequencing data to identify rare causal variants via hierarchical modeling
por: Capanu, Marinela, et al.
Publicado: (2015)

Prognostic value of circumferential radial margin involvement in esophagectomy for esophageal cancer: a case series
por: Boerner, Thomas, et al.
Publicado: (2023)

Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
por: Magahis, Patrick T, et al.
Publicado: (2023)

Perioperative discordance in mesothelioma cell type after pleurectomy/decortication—a possible detrimental effect of neoadjuvant chemotherapy due to epithelial to mesenchymal transition?
por: Ventura, Luigi, et al.
Publicado: (2023)

Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma
por: Fields, R C, et al.
Publicado: (2011)

Clinical Effectiveness of Neoadjuvant Chemotherapy in Gastric Carcinoma and Exploration of Perioperative Imaging Assessment Parameters
por: Lai, Jiajun, et al.
Publicado: (2021)

Association between Pre-Treatment Biological Indicators and Compliance to Neoadjuvant/Perioperative Chemotherapy in Operable Gastric Cancer
por: Monti, Manlio, et al.
Publicado: (2023)

Total Neoadjuvant vs. Standard Perioperative Cisplatin/Doxorubicin Chemotherapy in Patients with Extremities Osteosarcoma: A Multi-Center Cohort Study
por: Foroughi, Ahmad, et al.
Publicado: (2023)

Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab compared with chemotherapy alone and chemoradiotherapy for locally advanced esophageal squamous cell cancer
por: Zhang, Baihua, et al.
Publicado: (2023)

KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma
por: Tabernero, Josep, et al.
Publicado: (2021)

Perioperative chemotherapy versus neoadjuvant chemoradiation for patients with adenocarcinoma of the distal esophagus in Austria: a retrospective analysis
por: Koch, Oliver O., et al.
Publicado: (2019)

Neoadjuvant chemotherapy is associated with a high rate of perioperative blood transfusion at the time of interval cytoreductive surgery
por: McCool, Kevin W, et al.
Publicado: (2018)

Perioperative Complications and Safety Evaluation of Robot-Assisted Radical Hysterectomy of Cervical Cancer After Neoadjuvant Chemotherapy
por: Chang, Wei-Fu, et al.
Publicado: (2020)

Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma
por: Askan, Gokce, et al.
Publicado: (2021)

Survival benefit of neoadjuvant chemotherapy in pathologic T2N0 or lower urothelial carcinoma patients: evidence to support the use of neoadjuvant chemotherapy
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin
por: Clark, Mitchell, et al.
Publicado: (2021)

Perioperative outcomes of neoadjuvant immunotherapy plus chemotherapy and neoadjuvant chemoradiotherapy in the treatment of locally advanced esophageal squamous cell carcinoma: a retrospective comparative cohort study
por: Zhang, Hai, et al.
Publicado: (2023)

Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications
por: Deig, Christopher Ryan, et al.
Publicado: (2022)

Associations of Body Fat Distribution and Cardiometabolic Risk of Testicular Cancer Survivors After Cisplatin-Based Chemotherapy
por: Wibmer, Andreas G, et al.
Publicado: (2022)

Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Perioperative and Survival Outcomes
por: Ma, Xiao, et al.
Publicado: (2022)

Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI()
por: Tudorica, Alina, et al.
Publicado: (2016)

Perioperative safety and feasibility outcomes of stage IIIA-N2 non-small cell lung cancer following neoadjuvant immunotherapy or neoadjuvant chemotherapy: a retrospective study
por: Huang, Zhangfeng, et al.
Publicado: (2021)

Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma
por: Yu, Kenneth H., et al.
Publicado: (2018)

Clinical effects of Apatinib combined with DOS neoadjuvant chemotherapy regimen in neoadjuvant chemotherapy for LAGC
por: Zhou, Peng-zhe, et al.
Publicado: (2021)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
por: Wong, Willard, et al.
Publicado: (2021)

ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications
por: El Jabbour, Tony, et al.
Publicado: (2022)

Neoadjuvant chemoradiation versus perioperative chemotherapy followed by surgery in resectable adenocarcinomas of the esophagogastric junction: A retrospective single center analysis
por: SCHULZE, BJÖRN, et al.
Publicado: (2014)

Neoadjuvant Chemotherapy for Colon Cancer
por: Roth, Marc T., et al.
Publicado: (2020)

Identification of Rare Causal Variants in Sequence-Based Studies: Methods and Applications to VPS13B, a Gene Involved in Cohen Syndrome and Autism
por: Ionita-Laza, Iuliana, et al.
Publicado: (2014)

Monitoring early responses to neoadjuvant chemotherapy and the factors affecting neoadjuvant chemotherapy responses in primary osteosarcoma
por: Yu, Hong, et al.
Publicado: (2023)

Combined modality chemoradiation in elderly oesophageal cancer patients
por: Anderson, S E, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ma5gp8hc2hrsj01gnem504m3sq